Corneal tissue is not usually taken from persons with signs of viral hepatitis at the time of death. The viruses responsible are highly infectious and the practice would be considered hazardous both to the recipient of the cornea and to eye bank personnel. The hepatitis A and E viruses are transmitted principally by the faecal-oral route, have a relatively brief viraemic phase, and do not persist after recovery from illness. Hepatitis D virus (HDV) can persist, but is able only to multiply in cells that are co-infected with hepatitis B virus (HBV). The two agents of particular concern in transplantation are HBV and hepatitis C virus (HCV) because of their ability to persist in some individuals for years after resolution of symptoms. In Western countries, positive HBV serology is a relatively infrequent reason for withholding eye bank material This is due to the low prevalence of HBV carriage (< 1%) and the donor exclusion criteria in place to counter HIV-1. In regions of high carriage, however, the loss of otherwise useful tissue can be significant. For example, the preva- The transmission of any of these diseases to an otherwise healthy recipient is unacceptable in the context of an elective procedure. Most eye banks accept a positive HBsAg blood test as being a contraindication for use of the material and do not request further evidence of infectivity. Where there is a high prevalence of HBV infection and a scarcity of graft material, an eye bank might be tempted to offer tissue from HBsAg positive donors to HBV antibody positive recipients. Given that our understanding of the pathogenesis of HBV (and particularly HDV) infection is far from complete, this would have to be regarded as a risk justifiable only in an absolute emergency. Eye banks should err on the side of caution when assessing the suitability of donors. If there is a suspicion that an infectious agent has been transmitted through a corneal graft, an eye bank that has based its operation on the EBAA standards is well placed to defend itself. 
